MG, A., J, W., SM, O., S, K., & RP, G. (2020). Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study. Dove Medical Press.
Cita Chicago Style (17a ed.)MG, Asahi, Wallsh J, Onishi SM, Kuroyama S, y Gallemore RP. Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study. Dove Medical Press, 2020.
Cita MLA (8a ed.)MG, Asahi, et al. Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study. Dove Medical Press, 2020.
Precaución: Estas citas no son 100% exactas.